EVISA Glossary on | Contact EVISA | Sitemap | Home   
 Advanced search
The establishment of EVISA is funded by the EU through the Fifth Framework Programme (G7RT- CT- 2002- 05112).


Supporters of EVISA includes:



Biomedicine and Pharmacotherapy


 

Status
active
Indexing
BIOSIS/Biological Abstracts; Current Contents/Life Sciences; EMBASE/Excerpta Medica; Elsevier BIOBASE; MEDLINE®; Pascal/INIST-CNRS; SCISEARCH; Science Citation Index; ScienceDirect; Scopus
Predecessor
Subject

Source type
Journal
Publisher
ISBN ISSN
0753-3322
First volume
43
Last volume
62+
Homepage
Description
An international multidisciplinary journal with two objectives:
  • to create an interface between clinical and laboratory responses to drugs and to investigate critical approaches to different pathologies with regard to biological and clinical data,
  • to provide a niche for authors whose work is not directly defined by the review criteria of existing journals.

Biomedicine and pharmacotherapy is one of the few journals at the forefront of fundamental and technical science, biological and medical disciplines, therapeutics and pathological description. General fields of interest include molecular and cell biology, genetic disease, immunology and immunoregulation and chemotherapy. Special emphasis is placed on studies of specific topics such as differentiation, pharmacology and toxicology, preclinical and clinical pharmacology, the effects of drugs on cell structural and functional elements, the mechanism of gene regulation in normal and pathological cells, the role of viruses and parasites and the therapy of the diseases they induce. Brief reports of meetings, symposia and conferences will also be considered for publication as well as announcements of scientific meetings or academic courses.


Related links:









Imprint     Disclaimer

© 2003 - 2010 by European Virtual Institute for Speciation Analysis ( EVISA )